LA
CDIO icon

Linden Advisors’s Cardio Diagnostics CDIO Stock Holding History

Linden Advisors’s Portfolio CDIO Stock Details CDIO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-1,521
Closed -$114K – 319
2023
Q4 		$114K Hold
1,521
– – ﹤0.01% 221
2023
Q3 		$15.5K Hold
1,521
– – ﹤0.01% 311
2023
Q2 		$54.3K Sell
1,521
-1,336
-47% -$75.4K ﹤0.01% 264
2023
Q1 		$335K Hold
2,857
– – ﹤0.01% 273
2022
Q4 		$95.1K Buy
+2,857
New +$309K ﹤0.01% 385

Other funds holding CDIO

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
PNC Financial Services Group
PNC Financial Services Group Pittsburgh, Pennsylvania $202B AUM 37.79% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return
TSS
Two Sigma Securities New York $1.16B AUM 36.23% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
Vontobel Holding
Vontobel Holding Zurich, Switzerland $31.4B AUM 31.97% 1-Year Est. Return
CSC
Caldwell Sutter Capital Sausalito, California $265M AUM 30.15% 1-Year Est. Return

Linden Advisors's CDIO Position: Q1 2024 in Review

Linden Advisors sold out of Cardio Diagnostics (CDIO) in Q1 2024, closing a stake of 1,521 shares — an estimated $114K sold.

Linden Advisors first reported a position in CDIO in Q4 2022 and held it in 5 quarters. The position peaked at $335K in Q1 2023. 14 funds tracked by Wall St. Rank hold CDIO as of Q1 2024.

  • Linden Advisors reported no remaining Cardio Diagnostics position as of Q1 2024 after selling out during the quarter.
  • Linden Advisors sold 1,521 Cardio Diagnostics shares in Q1 2024, an estimated $114K.
  • Linden Advisors first reported a position in Cardio Diagnostics in Q4 2022 and held it in 5 quarters.
  • Linden Advisors's Cardio Diagnostics position peaked at $335K in Q1 2023.
  • 14 funds tracked by Wall St. Rank held Cardio Diagnostics as of Q1 2024.

Based on Linden Advisors's 13F filing for Q1 2024, filed 15 May 2024.